Charles (David) Collier
Lawyers
Filters
General Motors Financial $1.5 billion senior notes offering
The investment-grade notes are due 2028 and 2033
Prometheus Biosciences $500 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Axon $690 million convertible senior notes offering
The 0.50% convertible notes are due 2027
Ormat Technologies $338 million secondary offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
NextGen Healthcare $275 million convertible senior notes offering
The 3.75% convertible notes are due 2027
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Recursion Pharmaceuticals $150 million private placement
We advised the placement agents on the private placement of common stock
General Motors Financial $1.2 billion senior notes offering
The investment-grade notes are due 2025
Arco Platform acquisition of isaac
We are advising Arco Platform on the acquisition
GeoPark consent solicitation
We advised GeoPark on the transaction